Skip to main content Accessibility help
×
Home
  • Print publication year: 2009
  • Online publication date: September 2009

Section 1 - Diagnosis

References

BabikianV, RopperAH.Binswanger’s disease: a review. Stroke 1987; 18: 2–12.
BowlerJV, SteenhuisR, HachinskiV. Conceptual background of vascular cognitive impairment. Alzheimer Dis Assoc Disord 1999; 13: S30–7.
ChuiHC.Dementia: a review emphasizing clinicopathologic correlation and brain–behavior relationships. Arch Neurol 1989; 46: 806–14.
ChuiHC. Rethinking vascular dementia: moving from myth to mechanism. In: GrowdonJH, RossorMN, eds. The Dementias. Boston: Butterworth-Heinemann. 1998; 377–401.
ChuiHC.VictoroffJI, MargolinD, JagustW, ShankleR, KatzmanR. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology 1992; 42: 473–80.
ChuiHC.MackW, JacksonJE, et al. Clinical criteria for the diagnosis of vascular dementia. Arch Neurol 2000; 57: 191–6.
CummingsJL. Fronto-subcortical circuits and human behavior. Arch Neurol 1993; 50: 873–80.
Vascular subcortical dementias: clinical aspects. Dementia 1994; 5: 177–80.
de la TorreJC. Alzheimer’s disease is a vasocognopathy: a new term to describe its nature. Neurol Res 2004; 26: 517–24.
DeCarliC. Vascular factors in dementia: an overview. J Neurol Sci 2004; 226: 19–23.
DesmondDW. Vascular dementia: a construct in evolution. Cerebrovasc Brain Metab Rev 1996; 8: 96–325.
ErkinjunttiT.Types of multi-infarct dementia. Acta Neurol Scand 1987; 75: 391–9.
ErkinjunttiT.HachinskiVC.Rethinking vascular dementia. Cerebrovasc Dis 1993; 3: 3–23.
ErkinjunttiT.OstbyeT, SteenhuisR, HachinskiV. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 1997; 337: 1667–74.
ErkinjunttiT.InzitariD, PantoniL, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transam 2000; 59: 23–30.
FratiglioniL, LaunerLJ, AndersenK, et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 2000; 54: S10–15.
GoldG, GiannakopoulosP, Montes-PaixaoJC, et al. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 1997 49: 690–4.
GoldG, BourasC, CanutoA, et al. Clinicopathological validation study of four sets of clinical criteria for vascular dementia. Am J Psychiatry 2002; 159: 82–7.
GorelickPB. Status of risk factors for dementia associated with stroke. Stroke 1997; 28: 459–63.
HachinskiV. Preventable senility: a call for action against the vascular dementias. J Am Ger Soc 1992; 340: 645–8.
HebertR, BrayneC. Epidemiology of vascular dementia. [Review] [75 refs]. Neuroepidemiology 1995; 14: 240–57.
KalariaRN, BallardC.Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1999; 13: S115–23.
KennyRA, BallardCG, PerryR, InceP, PolvikoskiT. Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 2004; 226: 75–80.
KivpeltoM, NganduT, LaatikainenT, WinbladB, SoininenH, TuomilehtoJ.Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 2006; 5: 735–41.
LangaKM, ForsterNL, LarsonEB. Mixed dementia: emerging concepts and therapeutic implications. JAMA 2004; 292: 2901–08.
LeysD, HenonH, Mackowiak-Cordoliani M-A, Pasquier F. Poststroke dementia. Lancet Neurol 2005; 4: 752–9.
LindenT, SkoogI, Fagerber B, SteenB, BlomstrandC. Cognitive impairment and dementia 20 months after stroke. Neuroepidemiology 2004; 23: 45–52.
LoboA, LaunerLJ, FratiglioniL, et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurology 2000; 54: S4–S9.
LopezOL, LarumbeMR, BeckerJT, et al. Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia. Neurology 1994; 44: 1240–5.
MahlerME, CummingsJL. The behavioural neurology of multi-infarct dementia. Alzheimer Dis Assoc Disord 1991; 5: 122–30.
MoroneyJT, BagiellaE, DesmondDW, PaikMC, SternY, TatemichiTK. Risk factors for incident dementia after stroke. Role of hypoxic and ischemic disorders. Stroke 1996; 27: 1283–9.
MoroneyJT, BagiellaE, DesmondDW, PaikMC, SternY, TatemichiTK. Cerebral hypoxia and ischemia in the pathogenesis of dementia after stroke. Ann NY Acad Sci 1997; 826: 433–6.
MoroneyJT, BagiellaE, DesmondDW, et al. Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology 1997; 49: 1096–105.
Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). J Am Ger Soc 2001; 357: 169–75.
O’BrienJT, ErkinjunttiT, ReisbergB, et al. Vascular cognitive impairment. Lancet Neurology 2003; 2: 89–98.
PantoniL, GarciaJH. Pathogenesis of leukoaraiosis: a review. Stroke 1997; 28: 652–9.
PetersenRC, DoodyR, KurzA, et al. Current concepts in mild cognitive impairment. Arch Neurol 2002; 58: 1985–92.
PohjasvaaraT, ErkinjunttiT, VatajaR, KasteM.Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke 1997; 28: 785–92.
PohjasvaaraT, ErkinjunttiT, YlikoskiR, HietanenM, VatajaR, KasteM. Clinical determinants of poststroke dementia. Stroke 1998; 29: 75–81.
PohjasvaaraT, MäntyläR, SalonenO, et al. How complex interactions of ischemic brain infarcts, white matter lesions and atrophy relate to posstroke dementia. Arch Neurol 2000; 57: 1295–300.
PrinsND, van DijkEJ, den HeijerT, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004; 61: 1503–04.
RockwoodK, WenzelC, HachinskiV, HoganDB, MacKnightC, McDowellI.Prevalence and outcomes of vascular cognitive impairment. Neurology 2000; 54: 447–51.
RockwoodK, HowardK, MacKnightC, DarveshS. Spectrum of disease in vascular cognitive impairment. Neuroepidemiology 1999; 18: 248–54.
RomanGC, KalariaRN. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol Aging 2006; 27: 1769–85.
RomanGC, TatemichiTK, ErkinjunttiT, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Work Group. Neurology 1993; 43: 250–60.
RomanGC, ErkinjunttiT, WallinA, PantoniL, ChuiHC. Subcortical ischemic vascular dementia. Lancet Neurol 2002; 1: 426–36.
RomanGC, SachdevP, RoyallDR, et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci 2004; 226: 81–7.
SkoogI. Status of risk factors for vascular dementia. [Review] [89 refs]. Neuroepidemiology 1998; 17: 2–9.
SkoogI, KalariaRN, BretelerMMB. Vascular factors and Alzheimer’s disease. Alzheimer Dis Assoc Disord 1999; 13: S106–14.
SnowdonDA, GreinerLH, MortimerJA, RileyKP, GreinerPA, MarkesberyWR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997; 277: 813–17.
TatemichiTK.How acute brain failure becomes chronic. A view of the mechanisms and syndromes of dementia related to stroke. Neurology 1990; 40: 1652–9.
VatajaR, PohjasvaaraT, MäntyläR, et al. MRI correlates of executive dysfunction in patients with ischemic stroke. Eur J Neurol 2003; 10: 625–631.
VatajaR, PohjasvaaraT, MäntyläR, et al. Depressio-executive dysfunction syndrome in stroke patients. Am J Ger Psychiatry 2005; 13: 99–107.
VermeerSE, PrinsND, den HeijerT, HofmanA, KloudstaalPJ, BretelerMM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215–22.
WallinA, MilosV, SjögrenM, PantoniL, ErkinjunttiT. Classification and subtypes of vascular dementia. Int Psychoger 2003; 15: 27.
WallinA, BlennowK, GottfriesCG. Neurochemical abnormalities in vascular dementia. Dementia 2002; 1: 120–30.

References

AizensteinHJ, ButtersMA, ClarkKA, et al. Prefrontal and striatal activation in elderly subjects during concurrent implicit and explicit sequence learning. Neurobiol Aging 2006; 27: 741–51.
AlexanderGE, DeLongMR, StrickPL.Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 1986; 9: 357–81.
AntikainenR, JousilahtiP, TuomilehtoJ.Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population. J Hypertens 1998; 16: 577–83.
AuR, MassaroJM, WolfPA, et al. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol 2006; 63: 246–50.
AuerDP, PutzB, GosslC, ElbelG, GasserT, DichgansM.Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology 2001; 218: 443–51.
BaddeleyA.Working memory: looking back and looking forward. Nat Rev Neurosci 2003; 4: 829–39.
BarberR, ScheltensP, GholkarA, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 1999; 67: 66–72.
BennettDA, GilleyDW, WilsonRS, HuckmanMS, FoxJH.Clinical correlates of high signal lesions on magnetic resonance imaging in Alzheimer’s disease. J Neurol 1992; 239: 186–90.
BennettDA, GilleyDW, LeeS, CochranEJ.White matter changes: neurobehavioral manifestations of Binswanger’s disease and clinical correlates in Alzheimer’s disease. Dementia 1994; 5: 148–52.
BlumenfeldRS, RanganathC.Dorsolateral prefrontal cortex promotes long-term memory formation through its role in working memory organization. J Neurosci 2006; 26: 916–25.
BondareffW, RavalJ, CollettiPM, HauserDL.Quantitative magnetic resonance imaging and the severity of dementia in Alzheimer’s disease. Am J Psychiatry 1988; 145: 853–6.
BondareffW, RavalJ, WooB, HauserDL, CollettiPM.Magnetic resonance imaging and the severity of dementia in older adults. Arch Gen Psychiatry 1990; 47: 47–51.
BoonA, LodderJ, Heuts-van RaakL, KesselsF. Silent brain infarcts in 755 consecutive patients with a first-ever supratentorial ischemic stroke. Relationship with index-stroke subtype, vascular risk factors, and mortality. Stroke 1994; 25: 2384–90.
BooneKB, MillerBL, LesserIM, MehringerCM, HillE, BermanN.Cognitive deficits with white-matter lesions in healthy elderly. Arch Neruol 1992; 49: 549–54.
BretelerMM.Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Ann NY Acad Sci 2000; 903: 457–65.
BretelerMM, van AmerongenNM, van SwietenJCet al. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on MRI: the Rotterdam Study. Stroke 1994; 25: 1109–15.
BrilliantM, HughesL, AndersonD, GhobrialM, ElbleR.Rarefied white matter in patients with Alzheimer disease. Alzheimer Dis Assoc Disord 1995; 9: 39–46.
BrottT, TomsickT, FeinbergW, et al. Baseline silent cerebral infarction in the Asymptomatic Carotid Atherosclerosis Study. Stroke 1994; 25: 1122–9.
BrustJCM. Vascular dementia is overdiagnosed. Arch Neurol 1988; 45: 799–801.
BucknerRL.Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron 2004; 44: 195–208.
BurrussJW, HurleyRA, TaberKH, RauchRA, NortonRE, HaymanLA.Functional neuroanatomy of the frontal lobe circuits. Radiology 2000; 214: 227–30.
CabezaR.Hemispheric asymmetry reduction in older adults: the HAROLD model. Psychol Aging 2002; 17: 85–100.
CaplanLR.Binswanger’s disease – revisited. Neurology 1995; 45: 626–33.
CavadaC, Goldman-RakicPS.Posterior parietal cortex in rhesus monkey: I. Parcellation of areas based on distinctive limbic and sensory corticocortical connections. J Comp Neurol 1989a; 287: 393–421.
CavadaC, Goldman-RakicPS.Posterior parietal cortex in rhesus monkey: II. Evidence for segregated corticocortical networks linking sensory and limbic areas with the frontal lobe. J Comp Neurol 1989b; 287: 422–45.
ChuiHC, ZarowC, MackWJ, et al. Cognitive impact of subcortical vascular and Alzheimer’s disease pathology. Ann Neurol 2006; 60: 677–87.
CooperR, CutlerJ, Desvigne-NickensP, et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation 2000; 102: 3137–47.
CummingsJL.Frontal–subcortical circuits and human behavior. Arch Neurol 1993; 50: 873–80.
CummingsJL. Anatomic and behavioral aspects of frontal–subcortical circuits. In: GrafmanJ, HolyoakKJ, eds. Annals of the New York Academy of Sciences. New York: The New York Academy of Sciences, 1995: 1–13.
CummingsJL.Frontal–subcortical circuits and human behavior. J Psychosom Res 1998; 44: 627–8.
D’AgostinoRB, WolfPA, BelangerAJ, KannelWB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 1994; 25: 40–3.
de GrootJC, de LeeuwFE, BretelerMM.Cognitive correlates of cerebral white matter changes. J Neural Transm Supplementum 1998; 53: 41–67.
de GrootJC, de LeeuwFE, OudkerkM, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study . Ann Neurol 2000; 47: 145–51.
de LeeuwFE, Cees De GrootJ, OudkerkM, et al. Aortic atherosclerosis at middle age predicts cerebral white matter lesions in the elderly. Stroke 2000; 31: 425–9.
de LeeuwFE, de GrootJC, AchtenE, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001; 70: 9–14.
DeCarliC, MurphyDG, TranhM, et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995; 45: 2077–84.
DeCarliC, MillerBL, SwanGE, et al. Predictors of brain morphology for the men of the NHLBI twin study. Stroke 1999; 30: 529–36.
DeCarliC, MillerBL, SwanGE, ReedT, WolfPA, CarmelliD.Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 2001; 58: 643–7.
DeCarliC, MungasD, HarveyD, et al. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology 2004; 63: 220–7.
DeCarliC, FletcherE, RameyV, HarveyD, JagustWJ.Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke 2005; 36: 50–5.
DeCarliC, MassaroJ, HarveyD, et al. Measures of brain morphology and infarction in the Framingham heart study: establishing what is normal. Neurobiol Aging 2005b; 26: 491–510.
DiazJF, MerskeyH, HachinskiVC, et al. Improved recognition of leukoaraiosis and cognitive impairment in Alzheimer’s disease. Arch Neurol 1991; 48: 1022–5.
DichgansM.Monogenic causes of stroke. Int Psychoger 2003; 15 Suppl 1: 15–22.
DichgansM., FilippiM, BruningR, et al. Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology 1999; 52: 1361–7.
DoodyRS, MassmanPJ, MawadM, NanceM.Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer’s disease: comparison to small vessel ischemic vascular dementia. Neuropsychiatry Neuropsychol Behav Neurol 1998; 11: 191–9.
DuAT, SchuffN, ChaoLL, et al. White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy. Neurobiol Aging 2005; 26: 553–9.
DufouilC, ChalmersJ, CoskunO, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005; 112: 1644–50.
EliasMF, WolfPA, D’AgostinoRB, CobbJ, WhiteLR.Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol 1993; 138: 353–64.
EliasMF, SullivanLM, D’AgostinoRB, et al. Framingham stroke risk profile and lowered cognitive performance. Stroke 2004; 35: 404–09.
EliasMF, D’AgostinoRB, EliasPK, WolfPA.Neuropsychological test performance, cognitive functioning, blood pressure, and age: the Framingham Heart Study. Exp Aging Res 1995a; 21: 369–91.
EliasMF, D’AgostinoRB, EliasMF, WolfPA.Blood pressure, hypertension, and age as risk factors for poor cognitive performance. Exp Aging Res 1995b; 21: 393–417.
EsiriMM, NagyZ, SmithMZ, BarnetsonL, SmithAD.Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer’s disease. Lancet 1999; 354: 919–20.
EvansDA, FunkensteinHH, AlbertMS, et al. Prevalence of Alzheimer’s disease in a community population of older persons. Higher than previously reported. JAMA 1989; 262: 2551–6.
EzekowitzMD, JamesKE, NazarianSM, et al. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Circulation 1995; 92: 2178–82.
FazekasF, ChawlukJB, AlaviA, HurtigHI, ZimmermanRA.MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Neuroradiol 1987; 8: 421–6.
FazekasF, KapellerP, SchmidtR, OffenbacherH, PayerF, FazekasG.The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer’s disease. J Neurol Sci 1996; 142: 121–5.
FeinG, Di SclafaniV, TanabeJ, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 2000; 55: 1626–35.
GeschwindN.Disconnexion syndromes in animals and man. I. Brain 1965a; 88: 237–94.
GeschwindN, Disconnexion syndromes in animals and man. II. Brain 1965b; 88: 585–644.
GesztelyiG, FinneganW, DeMaroJA, WangJY, ChenJL, FenstermacherJ.Parenchymal microvascular systems and cerebral atrophy in spontaneously hypertensive rats. Brain Res 1993; 611: 249–57.
GillumRF.Coronary heart disease, stroke, and hypertension in a U.S. national cohort: the NHANES I Epidemiologic Follow-up Study. National Health and Nutrition Examination Survey. Ann Epidemiol 1996; 6: 259–62.
GoldJJ, HopkinsRO, SquireLR.Single-item memory, associative memory, and the human hippocampus. Learn Mem 2006; 13: 644–9.
Goldman-RakicPS.Circuitry of the frontal association cortex and its relevance to dementia. Arch Gerontol Geriatr 1987; 6: 299–309.
Goldman-RakicPS, Topography of cognition: parallel distributed networks in primate association cortex. Ann Rev Neurosci 1988; 11: 137–56.
GradyCL, CraikFI.Changes in memory processing with age. Curr Opin Neurobiol 2000; 10: 224–31.
Gunning-DixonFM, RazN.The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology 2000; 14: 224–32.
HachinskiV.Preventable senility: a call for action against the vascular dementias. Lancet 1992; 340: 645–8.
HachinskiV, PotterP, MerskeyH.Leuko-araiosis: an ancient term for a new problem. Can J Neurol Sci 1986; 13: 533–4.
HachinskiV, PotterP, MerskeyH.Leuko-araiosis. Arch Neurol 1987; 44: 21–3.
HanonO, ForetteF.Prevention of dementia: lessons from SYST-EUR and PROGRESS. J Neurol Sci 2004; 226: 71–4.
HanonO, SeuxML, LenoirH, RigaudAS, ForetteF.Prevention of dementia and cerebroprotection with antihypertensive drugs. Curr Hypertens Rep 2004; 6: 201–07.
HarrellLE, DuvallE, FolksDG, et al. The relationship of high-intensity signals on magnetic resonance images to cognitive and psychiatric state in Alzheimer’s disease. Arch Neurol 1991; 48: 1136–40.
HebertLE, BeckettLA, ScherrPA, EvansDA. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord 2001; 15: 169–73.
HenonH, DurieuI, GuerouaouD, LebertF, PasquierF, LeysD.Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 2001; 57: 1216–22.
JagustW.Untangling vascular dementia. Lancet 2001; 358: 2097–8.
JeerakathilT, WolfPA, BeiserA, et al. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 2004; 35: 1857–61.
JørgensenHS, NakayamaH, RaaschouHO, GamJ, OlsenTS. Silent infarction in acute stroke patients. Prevalence, localization, risk factors, and clinical significance: the Copenhagen Stroke Study. Stroke 1994; 25: 97–104.
KaseCS, WolfPA, ChodoshEH, et al. Prevalence of silent stroke in patients presenting with initial stroke: the Framingham Study. Stroke 1989; 20: 850–2.
KerteszA, PolkM, CarrT.Cognition and white matter changes on magnetic resonance imaging in dementia. Arch Neurol 1990; 47: 387–91.
KnopmanD, BolandLL, MosleyT, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001; 56: 42–8.
KnopmanD, ParisiJE, BoeveBF, et al. Vascular dementia in a population-based autopsy study. Arch Neurol 2003; 60: 569–75.
KozachukWE, DeCarliC, SchapiroMB, WagnerEE, RapoportSI, HorwitzB.White matter hyperintensities in dementia of Alzheimer’s type and in healthy subjects without cerebrovascular risk factors: a magnetic resonance imaging study. Arch Neurol 1990; 47: 1306–10.
KullerLH, LopezOL, NewmanA, et al. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 2003; 22: 13–22.
LaunerLJ. The epidemiologic study of dementia: a life-long quest?Neurobiol Aging 2005; 26: 335–40.
LaunerLJ, MasakiK, PetrovichH, FoleyD, Havlik, RJ.The association between mid-life blood pressure levels and late-life cognitive function. The Honolulu–Asia Aging Study. JAMA 1995; 274.
LeysD, SoetaertG, PetitH, FauquetteA, PruvoJP, SteinlingM.Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer’s disease and normal aging. Arch Neurol 1990; 47: 524–7.
LiaoD, CooperL, CaiJ, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke 1996; 27: 2262–70.
LiaoD, CooperL, CaiJ, et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology 1997; 16: 149–62.
LiemMK, van der GrondJ, HaanJ, et al. Lacunar infarcts are the main correlate with cognitive dysfunction in CADASIL. Stroke 2007; 38: 923–8.
LongstrethWT, Jr., ManolioTA, ArnoldA, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27: 1274–82.
LongstrethWT, Jr., BernickC, ManolioTA, BryanN, JungreisCA, PriceTR.Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol 1998; 55: 1217–25.
LongstrethWT, Jr., ArnoldAM, ManolioTA, et al. Clinical correlates of ventricular and sulcal size on cranial magnetic resonance imaging of 3,301 elderly people. The Cardiovascular Health Study. Collaborative Research Group. Neuroepidemiology 2000; 19: 30–42.
LopezOL, BeckerJT, RezekD, et al. Neuropsychiatric correlates of cerebral white-matter radiolucencies in probable Alzheimer’s disease. Arch Neurol 1992; 49: 828–34.
LopezOL, BeckerJT, JungreisCA, et al. Computed tomography – but not magnetic resonance imaging – identified periventricular white-matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer’s disease. Arch Neurol 1995; 52: 659–64.
LopezOL, JagustWJ, DulbergC, et al. Risk factors for mild cognitive impairment in the cardiovascular health study cognition study: part 2. Arch Neurol 2003; 60: 1394–9.
ManolioTA, Kronmal RA, BurkeGLet al., Magnetic resonance abnormalities and cardiovascular disease in older adults: the Cardiovascular Health Study. Stroke 1994; 25: 318–27.
ManolioTA, BurkeGL, O’LearyDH, et al. Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: the Cardiovascular Health Study. CHS Collaborative Research Group. Arterioscler Thromb Vasc Biol 1999; 19: 356–65.
MarderK, RichardsM, BelloJ, et al. Clinical correlates of Alzheimer’s disease with and without silent radiographic abnormalities. Arch Neurol 1995; 52: 146–51.
MaderK, MathisCA, KlunkWE, PriceJC, DeKoskyST.Imaging technology for neurodegenerative diseases: progress toward detection of specific pathologies. Arch Neurol 2005; 62: 196–200.
McDonaldWM, KrishnanKR, DoraiswamyPM, et al. Magnetic resonance findings in patients with early-onset Alzheimer’s disease. Biol Psychiatry 1991; 29: 799–810.
MentisMJ, SalernoJ, HorwitzB, et al. Reduction of functional neuronal connectivity in long-term treated hypertension. Stroke 1994; 25: 601–7.
MesulamMM.Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol 1990; 28: 597–613.
MillerEK, AsaadWF. The prefrontal cortex, conjunction and cognition. In: GrafmanJ, ed. Handbook of Neuropsychology. St. Louis: Elsevier, 2002.
MilnerB, SquireLR, KandelER.Cognitive neuroscience and the study of memory. Neuron 1998; 20: 445–68.
MirsenTR, LeeDH, WongCJ, et al. Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain. Arch Neurol 1991; 48: 1015–21.
MiyaoS, TakanoA, TeramotoJ, TakahashiA.Leukoaraiosis in relation to prognosis for patients with lacunar infarction. Stroke 1992; 23: 1434–8.
MoroneyJT, BagiellaE, DesmondDW, PaikMC, SternY, TatemichiTK.Risk factors for incident dementia after stroke. Role of hypoxic and ischemic disorders. Stroke 1996; 27: 1283–9.
MoroneyJT, BagiellaE, DesmondDW, PaikMC, SternY, TatemichiTK.Cerebral hypoxia and ischemia in the pathogenesis of dementia after stroke. Ann NY Acad Sci 1997a; 826: 433–6.
LopezOLBagiellaE,TatemichiTK, PaikMC, SternY, DesmondDW.Dementia after stroke increases the risk of long-term stroke recurrence. Neurology 1997b; 48: 1317–25.
MorrisJC, PriceAL.Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer’s disease. J Mol Neurosci 2001; 17: 101–118.
MorrisJC, ScherrPA, HebertLE, et al. Association between blood pressure and cognitive function in a biracial community population of older persons. Neuroepidemiology 2002; 21: 123–30.
MorrisR, PandyaDN, PetridesM.Fiber system linking the mid-dorsolateral frontal cortex with the retrosplenial/presubicular region in the rhesus monkey. J Comp Neurol 1999; 407: 183–92.
MoscovitchM, NadelL, WinocurG, GilboaA, RosenbaumRS.The cognitive neuroscience of remote episodic, semantic and spatial memory. Curr Opin Neurobiol 2006; 16: 179–90.
MoscovitchM, JagustWJ, ReedBR, et al. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease. Neurology 2001a; 57: 2229–35.
MoscovitchM, ReedB, EllisWG, JagustWJ. The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. Arch Neurol 2001b; 58: 1243–7.
MungasD, ReedBR, JagustWJ, et al. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology 2002; 59: 867–73.
MungasD, HarveyD, ReedBR, et al. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology 2005; 65: 565–71.
NordahlCW, RanganathC, YonelinasAP, DeCarliC, ReedBR, JagustWJ.Different mechanisms of episodic memory failure in mild cognitive impairment. Neuropsychologia 2005; 43: 1688–97.
NordahlCW, RanganathC, YonelinasAP, DeCarliC, FletcherE, JagustWJ.White matter changes compromise prefrontal cortex function in healthy elderly individuals. J Cogn Neurosci 2006; 18: 418–29.
O’BrienJT, ErkinjunttiT, ReisbergB, et al. Vascular cognitive impairment. Lancet Neurol 2003; 2: 89–98.
O’BrienJT. Vascular dementia is underdiagnosed. Arch Neurol 1988; 45: 797–8.
O’SullivanM, MorrisRG, HuckstepB, JonesDK, WilliamsSC, MarkusHS.Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry 2004; 75: 441–7.
OttA, StolkRP, HofmanA, van HarskampF, GrobbeeDE, BretelerMM.Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996; 39: 1392–7.
OttA, StolkRP, van HarskampF, PolsHA, HofmanA, BretelerMM. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 1999; 53: 1937–42.
OttBR, FabermanRS, NotoRB, et al. A SPECT imaging study of MRI white matter hyperintensity in patients with degenerative dementia. Dement Geriatr Cogn Disord 1997; 8: 348–54.
PapademetriouV, NarayanP, RubinsH, CollinsD, RobinsS.Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein cholesterol levels, and desirable low-density lipoprotein cholesterol levels. HIT Investigators. Department of Veterans Affairs HDL Intervention Trial. Am Heart J 1998; 136: 734–40.
PetersN, OpherkC, DanekA, BallardC, HerzogJ, DichgansM.The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. Am J Psychiatry 2005; 162: 2078–85.
PetersN, HoltmannspotterM, OpherkC, et al. Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease. Neurology 2006; 66: 1517–22.
PetersenRC, SmithGE, WaringSC, IvnikRJ, TangalosEG, KokmenE.Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303–08.
PetridesM, PandyaDN.Dorsolateral prefrontal cortex: comparative cytoarchitectonic analysis in the human and the macaque brain and corticocortical connection patterns. Eur J Neurosci 1999; 11: 1011–36.
PriceJL, MorrisJC.Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Ann Neurol 1999; 45: 358–68.
PriceTR, ManolioTA, KronmalRA, et al. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 1997; 28: 1158–64.
RanganathC.Working memory for visual objects: complementary roles of inferior temporal, medial temporal, and prefrontal cortex. Neuroscience 2006; 139: 277–89.
RanganathC, JohnsonMK, D’EspositoM.Prefrontal activity associated with working memory and episodic long-term memory. Neuropsychologia 2003; 41: 378–89.
RappPR, AmaralDG.Individual differences in the cognitive and neurobiological consequences of normal aging. Trends Neurosci 1992; 15: 340–5.
RatnasabapathyY, LawesCM, AndersonCS. The Perindopril Protection Against Recurrent Stroke Study (PROGRESS): clinical implications for older patients with cerebrovascular disease. Drugs Aging 2003; 20: 241–51.
RazN, GunningFM, HeadD, et al. Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. Cerebral Cortex 1997; 7: 268–82.
ReedBR, EberlingJL, MungasD, WeinerMW, JagustWJ.Memory failure has different mechanisms in subcortical stroke and Alzheimer’s disease. Ann Neurol 2000; 48: 275–84.
ReedBR, EberlingJL, MungasD, WeinerM, JagustWJ.Frontal lobe hypometabolism predicts cognitive decline in patients with lacunar infarcts. Arch Neurol 2001; 58: 493–7.
RomanGC.Senile dementia of the Binswanger type: a vascular form of dementia in the elderly. JAMA 1987; 258: 1782–8.
RomanGC, TatemichiTK, ErkinjunttiT, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250–60.
RosenAC, PrullMW, O’HaraR, et al. Variable effects of aging on frontal lobe contributions to memory. Neuroreport 2002; 13: 2425–8.
RypmaB, D’EspositoM.Isolating the neural mechanisms of age-related changes in human working memory. Nat Neurosci 2000; 3: 509–15.
SalernoJA, MurphyDG, HorwitzB, et al. Brain atrophy in hypertension. A volumetric magnetic resonance imaging study. Hypertension 1992; 20: 340–8.
SayettaRB. Rates of senile dementia, Alzheimer’s type, in the Baltimore Longitudinal Study. J Chronic Dis 1986; 39: 271–86.
ScheltensP, BarkhofF, ValkJ, et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer’s disease: evidence for heterogeneity. Brain 1992; 115: 735–48.
ScheltensP, BarkhofF, LeysD, WoltersEC, RavidR, KamphorstW.Histopathologic correlates of white matter changes on MRI in Alzheimer’s disease and normal aging. Neurology 1995; 45: 883–8.
SchmidtR.Comparison of magnetic resonance imaging in Alzheimer’s disease, vascular dementia and normal aging. Eur Neurol 1992; 32: 164–9.
SchmidtR, FazekasF, KochM, et al. Magnetic resonance imaging cerebral abnormalities and neuropsychologic test performance in elderly hypertensive subjects. A case-control study. Arch Neurol 1995; 52: 905–10.
SchneiderJA, WilsonRS, CochranEJ, et al. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology 2003; 60: 1082–8.
SchneiderJA, WilsonRS, BieniasJL, EvansDA, BennettDA.Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 2004; 62: 1148–55.
SelemonLD, Goldman-RakicPS.Common cortical and subcortical targets of the dorsolateral prefrontal and posterior parietal cortices in the rhesus monkey: evidence for a distributed neural network subserving spatially guided behavior. J Neurosci 1988; 8: 4049–68.
SeshadriS, WolfPA, BeiserA, et al. Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology 2004; 63: 1591–9.
SeshadriS, BeiserA, Kelly-HayesM, et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006; 37: 345–50.
ShinkawaA, UedaK, KiyoharaY, et al. Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study. Stroke 1995; 26: 380–5.
SnowdonDA, GreinerLH, MortimerJA, RileyKP, GreinerPA, MarkesberyWR.Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997; 77.
SquireLR.Memory systems of the brain: a brief history and current perspective. Neurobiol Learn Mem 2004; 82: 171–7.
SquireLR, StarkCE, ClarkRE.The medial temporal lobe. Ann Rev Neurosci 2004; 27: 279–306.
StarksteinSE, SabeL, VazquezS, et al. Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1997; 63: 66–73.
SteingartA, LauK, FoxA, et al. The significance of white matter lucencies on CT scan in relation to cognitive impairment. Can J Neurol Sci 1986; 13: 383–4.
SteingartA, HachinskiVC, LauC, et al. Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch Neurol 1987; 44: 32–5.
StoutJC, JerniganTL, ArchibaldSL, SalmonDP.Association of dementia severity with cortical gray matter and abnormal white matter volumes in dementia of the Alzheimer type. Arch Neurol 1996:742–9.
StrassburgerTL, LeeHC, DalyEM, et al. Interactive effects of age and hypertension on volumes of brain structures. Stroke 1997; 28: 1410–7.
StreiflerJY, EliasziwM, FoxAJ, et al. Prognostic importance of leukoaraiosis in patients with ischemic events and carotid artery disease. Stroke 1999; 30: 254.
SullivanEV, PfefferbaumA.Diffusion tensor imaging and aging. Neurosci Biobehav Rev 2006; 30: 749–61.
SwanGE, DeCarliC, MillerBL, et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology 1998; 51: 986–93.
SwanGE, DeCarliC, MillerBL, ReedT, WolfPA, CarmelliD.Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy. Neurology 2000; 54: 2108–14.
SwartzRH, BlackSE.Anterior–medial thalamic lesions in dementia: frequent, and volume dependently associated with sudden cognitive decline. J Neurol Neurosurg Psychiatry 2006; 77: 1307–12.
TajimaA, HansFJ, LivingstoneD, et al. Smaller local brain volumes and cerebral atrophy in spontaneously hypertensive rats. Hypertension 1993; 21: 105–11.
TatemichiTK.How acute brain failure becomes chronic: a view of the mechanisms of dementia related to stroke. Neurology 1990; 40: 1652–9.
TatemichiTK, FoulkesMA, MohrJP, et al. Dementia in stroke survivors in the stroke data bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings. Stroke 1990; 21: 858–66.
TatemichiTK, DesmondDW, MayeuxR, et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992; 42: 1185–93.
TatemichiTK, DesmondDW, ProhovnikI.Strategic infarcts in vascular dementia. A clinical and brain imaging experience. Arzneimittel-Forschung 1995a; 45: 371–85.
TatemichiTK, DesmondDW, ProhovnikI, EidelbergD.Dementia associated with bilateral carotid occlusions: neuropsychological and haemodynamic course after extracranial to intracranial bypass surgery. J Neurol Neurosurg Psychiatry 1995b; 58: 633–6.
TeipelSJ, HampelH, AlexanderGE, et al. Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer’s disease. Neurology 1998; 51: 1381–5.
TekinS, CummingsJL.Frontal–subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002; 53: 647–54.
TullbergM, FletcherE, DeCarliC, et al. White matter lesions impair frontal lobe function regardless of their location. Neurology 2004; 63: 246–53.
TulvingE.Multiple memory systems and consciousness. Hum Neurobiol 1987; 6: 67–80.
Van der WerfVD, ScheltensP, LindeboomJ, WitterMP, UylingsHB, JollesJ.Deficits of memory, executive functioning and attention following infarction in the thalamus; a study of 22 cases with localised lesions. Neuropsychologia 2003; 41: 1330–44.
VermeerSE, KoudstaalPJ, OudkerkM, HofmanA, BretelerMM.Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2002; 33: 21–5.
VermeerSE, PrinsND, den HeijerT, HofmanA, KoudstaalPJ, BretelerMM.Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215–22.
WahlundLO, BasunH, AlmkvistO, Andersson-LundmanG, JulinP, SaafJ.White matter hyperintensities in dementia: does it matter?Magn Res Imag 1994; 12: 387–94.
WaldemarG, ChristiansenP, LarssonHB, et al. White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates. J Neurol Neurosurg Psychiatry 1994; 57: 1458–65.
WeberMA. Role of hypertension in coronary artery disease. Am J Nephrol 1996; 16: 210–16.
WenW, SachdevP.The topography of white matter hyperintensities on brain MRI in healthy 60- to 64-year-old individuals. Neuroimage 2004; 22: 144–54.
WestRL.An application of prefrontal cortex function theory to cognitive aging. Psychol Bull 1996; 120: 272–92.
WilsonRS, BeckettLA, BennettDA, AlbertMS, EvansDA.Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease. Arch Neurol 1999; 56: 1274–9.
WilsonRS, BeckettLA, BarnesLL, et al. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002; 17: 179–93.
WolfPA, D’AgostinoRB, BelangerAJ, KannelWB. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991; 22: 312–8.
WuCC, MungasD, PetkovCI, et al. Brain structure and cognition in a community sample of elderly Latinos. Neurology 2002; 59: 383–91.
YoshitaM, FletcherE, HarveyD, et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology 2006; 67: 2192–8.
YousryTA, SeelosK, MayerM, et al. Characteristic MR lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Am J Neuroradiol 1999; 20: 91–100.
YueNC, ArnoldAM, LongstrethWT, Jr., et al. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the cardiovascular health study. Radiology 1997; 202: 33–9.
ZhengZJ, SharrettAR, ChamblessLE, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 1997; 131: 115–25.

References

Aguerro-TorresH, FratiglioniL, GuoA, ViitanenM, WinbladB. Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm. J Am Geriatr Soc 1998; 46: 444–52.
American Psychiatric Association (APA). DSM-IV: Diagnostic and Statistic Manual of Mental Disorders, Fourth Edition. Washington, D.C.; American Psychiatric Association, 1994.
AttemsJ, JellingerKA.Only cerebral capillary amyloid angiography correlates with Alzheimer pathology – a pilot study. Acta Neuropathol 2004; 107: 83–90.
BarbaR, Martinez-EspinosaS, Rodriguez-GarciaE, PondalM, VivancosJ, Del SerT.Poststroke dementia. Clinical features and risk factors. Stroke 2000; 31: 1494–501.
BensonDF, CummingsJL, TsaiSY.Angular gyrus syndrome simulating Alzheimer’s disease. Arch Neurol 1982; 39: 616–20.
BogousslavskyJ, BernasconiA, KumralE. Acute multiple infarction involving the anterior circulation. Arch Neurol 1996; 53: 50–7.
BoitenJ, LodderJ.Large striatocapsular infarcts: clinical presentation and pathogenesis in comparison with lacunar and cortical infarcts. Acta Neurol Scand 1992; 86: 298–303.
BuffonF, PorcherR, HernandezK, et al. Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry 2006; 77: 175–80.
ChuiHC, MackW, JacksonJE, et al. Clinical criteria for the diagnosis of vascular dementia. Arch Neurol 2000; 57: 191–6.
ChuiHC, VictoroffJI, MargolinD, JagustW, ShankleR, KatzmanR. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology 1992; 42: 473–80.
ChuiHC, ZarowC, MackWJ, et al. Cognitive impact of subcortical vascular and Alzheimer’s disease pathology. Ann Neurol 2006; 60: 677–87.
Cordoliani-MackowiakM-A, HenonH, PruvoJ-P, PasquierF, LeysD.Poststroke dementia: the influence of hippocampal atrophy. Arch Neurol 2003; 60: 585–90.
DamasioAR, DamasioH.The anatomic basis of pure alexia. Neurology 1983; 33: 1573–83.
DamasioAR, EslingerPJ, DamasioH, Van HoesenGW, CornellS.Multimodal amnesic syndrome following bilateral temporal and basal forebrain damage. Arch Neurol 1985; 42: 252–9.
de GrootJC, de LeeuwFE, OudkerkM, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000; 47: 145–51.
De ReuckJ, CrevitsL, De CosterW, SiebenG, and van der EckenH.Pathogenesis of Binswanger chronic progressive subcortical encephalopathy. Neurology 1980; 30: 920–8.
del SerT, BermejoF, PorteraA, ArredondoJM, BourasC, ConstantinidisJ.Vascular dementia. A clinicopathological study. J Neurol Sci 1990; 96: 1–17.
DesmondDW, MoroneyJT, PaikMC, et al. Frequency and clinical determinants of dementia after ischemic stroke. Neurology 2000; 54: 1124–31.
ErkinjunntiT, InzitariD, PantoniL, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm (Suppl) 2000; 59: 23–30.
EsiriMM, WilcockGK, MorrisJH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997; 63: 749–53.
FolsteinMF, FolsteinSE, McHughPR. Mini-mental state: a practical method grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–98.
FreelsS, NyenhuisDL, GorelickPE. Predictors of survival in African American patients with AD, VaD, or stroke without dementia. Neurology 2002; 59: 1146–53.
FriedlandRP. “Normal’-pressure hydrocephalus and the saga of the treatable dementias. JAMA 1989; 262: 2577–93.
GalaskoD, ChangL, MotterR, et al. High cerebrospinal fluid tau and low amyloid B42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol 1998; 55: 937–45.
GalaskoD, HansenLA, KatzmanR.Clinical–neuropathological correlations in Alzheimer’s disease and related dementias. Arch Neurol 1994; 51: 888–95.
GoldG, BourasC, CanutoA, et al. Clinicopathological validation study of four sets of clinical criteria for vascular dementia. Am J Psychiatry 2002; 159: 82–7.
Graff-RadfordNR, EslingerPJ, DamasioAR, YamadaT.Nonhemorrhagic infarction of the thalamus: Behavioral, anatomic, and physiologic correlates. Neurology 1984; 34: 14–23.
GrahamNL, EmeryT, HodgesJR.Distinctive cognitive profiles in Alzheimer’s disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry 2004; 75: 61–71.
GrovesWC, BrandtJ, SteinbergM, et al. Vascular dementia and Alzheimer’s disease: is there a difference? A comparison of symptoms by disease duration. J Neuropsychiatry Clin Neurosci 2000; 12: 305–15.
HachinskiVC, LassenNA.Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 1974; 2: 207–10.
HebertR, LindsayJ, VarreaultR, RockwoodK, HillG, DuboisM-F. Vascular dementia: Incidence and risk factor in the Canadian study of Health and Aging. Stroke 2000; 31: 1487–93.
HenonH, DurieuI, GuerouaouD, LebertFFP, LeysD.Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 2001; 57: 1216–22.
HogervorstE, BandelowS, CombrinckM, IraniS, SmithAD.The validity and reliability of 6 sets of clinical criteria to classify Alzheimer’s disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach. Dement Geriatr Cogn Disord 2003; 16: 170–80.
HogervorstE, RibeiroHM, MolyneuxA, BudgeM, SmithAD.Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer’s disease. Arch Neurol 2002; 59: 787–93.
HolmesC, CairnsN, LantosP, MannA.Validity of current clinical criteria for Alzheimer’s disease, vascular dementia, and dementia with Lewy bodies. Br J Psychiatry 1999; 174: 45–50.
HuletteC, NochlinD, McKeelDW, et al. Clinical–neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology 1997; 48: 668–72.
IsoeK, UrikamiK, SatoK, TakahashiK. Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia. Acta Neurol Scand 1996; 93: 133–7.
JokinenH, KalskaH, MantylaR, et al. Cognitive profile of subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry 2006; 77: 28–33.
KatzDI, AlexanderMP, MandellAM.Dementia following strokes in the mesencephalon and diencephalon. Arch Neurol 1987; 44: 1127–33.
KnopmanDS, ParisiJE, BoeveBF, et al. Vascular dementia in a population-based autopsy study. Arch Neurol 2003; 60: 569–75.
KnopmanDS, RoccaWA, ChaRH, EdlandSD, KokmenE.Incidence of vascular dementia in Rochester, Minn, 1985–1989. Arch Neurol 2002; 59: 1605–10.
KullerLH, LopezOL, JagustWJ, et al. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology 2005; 64: 1548–52.
KullerLH, LopezOL, NewmanA, et al. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 2003; 22: 13–22.
KumralE, EvyapanD, BalkirD, KutluhanS.Bilateral thalamic infarction: Clinical, etiological and MRI correlates. Acta Neurol Scand 2001; 103: 35–42.
KumralE, EvyapanD, BalkirK.Acute caudate vascular lesions. Stroke 1999; 30: 100–08.
LibonDJ, PriceCC, DavisGK, GiovannettiT.From Binswanger’s disease to leukoaraiosis: what we have learned about subcortical vascular disease. Clin Neuropsychol 2004; 18: 83–100.
LindsayJ, HebertR,RockwoodK.The Canadian Study of Health and Aging: risk factors for vascular dementia. Stroke 1997; 28: 526–30.
LiuCK, MillerBL, CummingsJL, et al. A quantitative MRI study of vascular dementia. Neurology 1992; 42: 138–43.
LopezOL, BeckerJT, KlunkW, et al. Research evaluation and diagnosis of possible Alzheimer’s disease over the last two decades: II. Neurology 2000a; 55: 1863–9.
LopezOL, BeckerJT, KlunkW, et al. Research evaluation and diagnosis of probable Alzheimer’s disease over the last two decades: I. Neurology 2000b; 55: 1854–62.
LopezOL, ClaassenD.Cerebral amyloid angiopathy in Alzheimer’s disease: clinicopathological correlations. Dementia 1991; 2: 285–90.
LopezOL, KullerLH, BeckerJT, et al. Classification of vascular dementia in the Cardiovascular Health Study cognition study. Neurobiology 2005; 64: 1531–47.
LopezOL, KullerLH, FitzpatrickA, IvesD, BeckerJT, BeauchampN.Evaluations of dementia in the cardiovascular health cognition study. Neuroepidemiology 2003; 22: 1–12.
LopezOL, LarumbeMR, BeckerJT, et al. Reliability of NINDS-AIREN criteria for vascular dementia. Neurology 1994; 44: 1240–45.
LuchsingerJA, TangM-X, SternY, SheaS, MayeuxR.Am J Epidemiol 2001; 154: 635–41.
McMahonJA, GreenTJ, SkeaffCM, KnightRG, MannJI, WilliamsSM.A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 2006; 354: 2764–72.
MinWK, ParkKK, and KimYS.Atherothrombotic middle cerebral artery territory infarction: topography diversity with common occurrence of concomitant small cortical and subcortical infarcts. Stroke 2000; 31: 2055–61.
MolsaPK, MarttilaRJ, RinneUK.Long-term survival and predictors of mortality in Alzheimer’s disease and multi-infarct dementia. Arch Neurol Scand 1995; 91: 159–64.
MoroneyJT, BagiellaE, TatemichiTK, PaikMC, SternY, DesmondDW.Dementia after stroke increases the risk of long-term stroke recurrence. Neurology 1997; 48: 1317–25.
MyersRH, SchaeferEJ, WilsonPWF, et al. Apolipoprotein E e4 association with dementia in a population-based study: the Framingham Study. Neurology 1996; 46: 673–7.
NordahlCW, RanganathC, YonelinasAP, DeCarliC, ReedBR, JagustWJ. Different mechanisms of episodic memory failure in mild cognitive impairment. Neuropsychologia 2005; 43: 1688–97.
OttBR, SaverJL. Unilateral amnesic stroke. Six new cases and a review of the literature. Stroke 1993; 24: 1033–42.
ParnettiL, BottiglieriT, LowenthalD.Role of homocysteine in age-related vascular and non-vascular diseases. Aging (Milano) 1997; 9: 241–57.
PetersN, HerzogJ, OpherkC, DichgansM.A two-year clinical follow-up study in 80 CADASIL subjects. Stroke 2004; 35: 1603–08.
PetrovitchH, RossGW, SteinbornSC, et al. AD lesions and infarcts in demented and non-demented Japanese-American men. Ann Neurol 2005; 57: 98–103.
PfeiferLA, WhiteLR, RossGW, PetrovitchH, LaunerLJ.Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study. Neurology 2002; 58: 1629–34.
PohjasvaaraT, MantylaR, SalonenO, et al. How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol 2000; 57: 1295–300.
PohjasvaaraT, RittaM, YlikoskiR, MarkkuK, ErkinjunttiT. Clinical features of MRI-defined subcortical vascular disease. Alzheimer Dis Assoc Disord 2003; 17: 236–42.
PosnerHB, TangM-X, LuchsingerJ, LantiguaR, MayeuxR.The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 2002; 58: 1175–81.
PrinsN, van DijkE, den HeijerT, et al. Cerebral small-vessel disease and decline in information processing speed, executive function, and memory. Brain 2005; 128: 2034–41.
PrinsN, van DijkE, den HeijerT, VermeerS, KoudtsalP, OudkerkM.Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004; 61: 1503–04.
ReedBR, EberlingJL, MungasD, WeinerM, JagustWJ.Effects of white matter lesions and lacunes on cortical function. Arch Neurol 2004a; 58: 545–50.
ReedBR, MungasDM, KramerJH, et al. Clinical and neuropsychological features in autopsy-defined vascular dementia. Clin Neuropsychol 2004b; 18: 63–74.
RogaevaE, MengY, LeeJH, et al. The neuronal sortilin-related receptor SORLI is genetically associated with Alzheimer Disease. Nature Genetics 2007; 39: 168–77.
RomanGC.From UBOs to Binswanger’s disease: impact of magnetic resonance imaging on vascular dementia research. Stroke 1996; 27: 1269–73.
RomanGC, TatemichiTK, ErkinjunttiT, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250–60.
RossGW, PetrovichH, WhiteLR, et al. Characterization of risk factors for vascular dementia: the Honolulu-Asia Aging Study. Neurology 1993; 53: 337–43.
SchneiderJA, WilsonRS, CochranEJ, et al. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology 2003; 60: 1082–88.
SelnesOA, VintersHV.Vascular cognitive impairment. Nat Clin Pract Neurol 2006; 2: 538–47.
SlooterAJC, TangM, van DujinCM, et al. Apolipoprotein E epsilon4 and the risk of dementia with stroke: a population based investigation. JAMA 1997; 277: 818–21.
SnowdonDA, GrainerLH, MortimerJA, RileyKP, GrainerPA, MarkesberyWR.Brain infarction and the clinical expression of Alzheimer disease: the nun study. JAMA 1997; 277: 813–17.
StarksteinSE, RobinsonRG, BerthierML, PriceTR.Depressive disorders following posterior circulation as compared with middle cerebral artery infarcts. Brain 1988a; 111: 375–87.
StarksteinSE, RobinsonRG, PriceTR.Comparison of patients with and without poststroke major depression matched for size and location of lesion. Arch Gen Psychiat 1988b; 45: 247–52.
StarksteinSE, FederoffJP, PriceTR, LeiguardaR, RobinsonRG.Apathy following cerebrovascular lesions. Stroke 1993; 24: 1625–30.
StengardJH, PekkanenJ, SulkavaR, EhnholmC, ErkinjunttiT.Apolipoprotein E polymorphism, Alzheimer’s disease and vascular dementia among elderly Finnish men. Acta Neurol Scand 1995; 92: 297–8.
TatemichiTK, DesmondDW, MayeuxR, et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992a; 42: 1185–93.
TatemichiTK, DesmondDW, SternY, PaikM, BagiellaE.Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry 1994; 57: 202–07.
TatemichiTK, SteinkeW, DuncanC, et al. Paramedian thalamopeduncular infarction: clinical syndromes and magnetic resonance imaging. Ann Neurol 1992b; 32: 162–71.
TierneyMC, BlackSE, SzalaiJP, et al. Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Arch Neurol 2001; 58: 1654–9.
TomlinsonBE, BlessedG, RothM.Observations on the brain of demented old people. J Neurol Sci 1970; 11: 205–42.
van StraatenECW, Schelters P, Knol DL, et al. Operational definitions for the NINDS-AIREN criteria for vascular dementia. Stroke 2003; 34: 1907–16.
VerheyFR, LodderJ, RozendaalN, JollesL.Comparison of seven sets of criteria used for the diagnosis of vascular dementia. Neuroepidemiology 1996; 15: 166–72.
VermeerSE, PrinsND, den HeijerT, HofmanA, KoudstaalPJ, BretelerMMB. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215–22.
World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research. GenevaWHO, 1993.
WillisT.The London Practice of Physick. London, Dring Harper & Leigh, 1984.
ZekryD, DuyckaertsC, BelminJ, et al. The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy. Neurobiol Aging 2003; 24: 213–19.

References

Agüero-TorresH, KivipeltoM, von StraussE.Rethinking the dementia diagnosis in a population-based study: what is Alzheimer’s disease and what is vascular dementia? A study from the Kungsholmen Project. Dementia Geriatr Cogn Disord 2006; 22: 244–9.
AmberlaK, WäljasM, TuominenS, et al. Insidious cognitive decline in CADASIL. Stroke 2004; 35: 1598–602.
BäckmanL, JonesS, BergerA-K, et al. Cognitive impairment in preclinical Alzheimer’s disease: a meta-analysis. Neuropsychology 2005; 19: 520–31.
BaillonS, MuhommadS, MarudkarM, et al. Neuropsychological performance in Alzheimer’s disease and vascular dementia: comparisons in a memory clinic population. Int J Geriatr Psychiatry 2003; 18: 602–8.
BuffonF, PorcherR, HernandezK, et al. Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry 2006; 77: 175–80.
BurtonEJ, KennyRA, O’BrienJ, et al. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke 2004; 35: 1270–5.
CabezaR, NybergL.Imaging cognition II: an empirical review of 275 PET and fMRI studies. J Cogn Neurosci 2000; 12: 1–47.
CanningSJ, LeachL, StussD, et al. Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia. Neurology 2004; 62: 556–62.
ChabriatH, VahediK, Iba-ZizenMT, et al. Clinical spectrum of CADASIL: a study of 7 families. Lancet 1995; 346: 934–9.
CharltonRA, MorrisRG, NitkunanA, et al. The cognitive profiles of CADASIL and sporadic small vessel disease. Neurology 2006; 66: 1523–6.
CummingsJL.Frontal–subcortical circuits and human behavior. Neurol Rev 1993; 50: 873–80.
de GrootJC, de LeeuwF-E, OudkerkM, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000; 47: 145–51.
DesmondDW, The cognitive syndrome of vascular dementia: Implications for clinical trials. Alzheimer Dis Assoc Disord 1999; 13 (Suppl. 3): 21–9.
DesmondDW. The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit?J Neurol Sci 2004; 226: 3–7.
DuAT, SchuffN, LaaksoMP, et al. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology 2002; 58: 1635–41.
ErkinjunttiT, InzitariD, PantoniL, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm 2000; 59 (Suppl.): 23–30.
FahlanderK, WahlinÅ, AlmkvistO, et al. Cognitive functioning in Alzheimer’s disease and vascular dementia: further evidence for similar patterns of deficits. J Clin Exp Neuropsychol 2002; 24: 734–44.
FischerP, GattererG, MartererA, et al. Course characteristics in the differentiation of dementia of the Alzheimer type and multi-infarct dementia. Acta Psychiatr Scand 1990; 81: 551–3.
GrahamNL, EmeryT, HodgesJR.Distinctive cognitive profiles in Alzheimer’s disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry 2004; 75: 61–71.
HachinskiV, LassenNA, MarshallJ.Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet 1974; 2: 207–10.
HachinskiV, IadecolaC, PetersenRC, et al. National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular cognitive impairment harmonization standards. Stroke 2006; 37: 2220–41.
JokinenH, KalskaH, MäntyläR, et al. Cognitive profile of subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry 2006; 77: 28–33.
JonesS, LaukkaEJ, SmallBJ, et al. A preclinical phase in vascular dementia: cognitive impairment three years before diagnosis. Dementia Geriatr Cogn Disord 2004; 18: 233–9.
JonesS, LaukkaEJ, BäckmanL.Differential verbal fluency deficits in the preclinical stages of Alzheimer’s disease and vascular dementia. Cortex 2006; 42: 347–55.
KramerJH, ReedBR, MungasD, et al. Executive dysfunction in subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry 2002; 72: 217–20.
LaukkaEJ, JonesS, SmallBJ, et al. Similar patterns of cognitive deficits in the preclinical phases of vascular dementia and Alzheimer’s disease. J Int Neuropsychol Soc 2004; 10: 382–91.
LogroscinoG, KangJH, & GrodsteinF.Prospective study of type 2 diabetes and cognitive decline in women aged 70–81 years. British Medical Journal 2004; 328: 548.
MiyakeA, FriedmanNP, EmersonMJ, et al. The unity and diversity of executive functions and their contributions to complex “frontal lobe” tasks: a latent variable analysis. Cogn Psychol 2000; 41: 49–100.
OostermanJM, ScherderEJA.Distinguishing between vascular dementia and Alzheimer’s disease by means of the WAIS: a meta-analysis. J Clin Exp Neuropsychol 2006; 28: 1158–75.
O’SullivanM, BarrickTR, MorrisRG, et al. Damage within a network of white matter regions underlies executive dysfunction in CADASIL. Neurology 2005; 65: 1584–90.
PihlajamäkiM, TanilaH, HänninenT, et al. Verbal fluency activates the left medial temporal lobe: a functional magnetic resonance imaging study. Ann Neurol 2000; 47: 470–6.
ReedBR, EberlingJL, MungasD, et al. Memory failure has different mechanisms in subcortical stroke and Alzheimer’s disease. Ann Neurol 2000; 48: 275–84.
RomanGC, TatemichiTK, ErkinjunttiT, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurol 1993; 43: 250–60.
RomanGC, ErkinjunttiT, WallinA, et al. Subcortical ischaemic vascular dementia. Lancet Neurol 2002; 1: 426–36.
SachdevPS & LooiJCL. Neuropsychological differentiation of Alzheimer’s disease and vascular dementia. In Bowler JV, Hachinski V, eds. Vascular Cognitive Impairment: Preventable Dementia. New York: Oxford University Press, 2003.
SacuiuS, SjögrenM, JohanssonB, et al. Prodromal cognitive signs of dementia in 85-year-olds using four sources of information. Neurol 2005; 65: 1894–900.
SchmidtkeK,HüllM.Neuropsychological differentiation of small vessel disease, Alzheimer’s disease and mixed dementia. J Neurol Sci 2002; 203–4: 17–22.
SquireLR,ZolaSM. Structure and function of declarative and non-declarative memory systems. Proc Nat Acad Sci USA 1996; 93: 1315–22.
TierneyMC, BlackSE, SzalaiJP, et al. Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Arch Neurol 2001; 58: 1654–59.
TraykovL, BaudicS, RaouxN, et al. Patterns of memory impairment and perseverative behavior discriminate early Alzheimer’s disease from subcortical vascular dementia. J Neurol Sci 2005; 229–230: 75–9.
TullbergM, FletcherE, DeCarliC, et al. White matter lesions impair frontal lobe function regardless of their location. Neurol 2004; 63: 246–53.
TulvingE.Episodic memory: from mind to brain. Annu Rev Psychol 2002; 53: 1–25.
VanderploegRD, YuspehRL, and SchinkaJA.Differential episodic and semantic memory performance in Alzheimer’s disease and vascular dementias. J Int Neuropsychol Soc 2001; 7: 563–73.
VermeerSE, PrinsND, den HeijerT, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215–22.
VillarditaC.Alzheimer’s disease compared with cerebrovascular dementia. Neuropsychological similarities and differences. Acta Neurol Scand 1993; 87: 299–308.
YuspehRL, VanderploegRD, CrowellTA, et al. Differences in executive functioning between Alzheimer’s disease and subcortical ischemic vascular dementia. J Clin Exp Neuropsychol 2002; 24: 745–54.

References

BarberR, ScheltensP, GholkarA, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 1999a; 67(1): 66–72.
BarberR, GholkarA, ScheltensP, BallardC, McKeithIG, O’Brien JT. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 1999b; 52(6): 1153–58.
BarberR, BallardC, McKeithIG, GholkarA, O’Brien JT. MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. Neurology 2000; 54(6): 1304–09.
BasserPJ, PierpaoliC.Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 1996; 111(3): 209–19.
BastosLeite AJ, Van StraatenEC, ScheltensP, LycklamaG, BarkhofF.Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging. Stroke 2004; 35(2): 415–19.
ChabriatH, VahediK, Iba-ZizenMT, et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 1995; 346(8980): 934–9.
ChabriatH, PappataS, PouponC, et al. Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. Stroke 1999; 30(12): 2637–43.
CordonnierC, van der FlierWM, SluimerJD, LeysD, BarkhofF, ScheltensP.Prevalence and severity of microbleeds in a memory clinic setting. Neurology 2006; 66(9): 1356–60.
den HeijerT, VermeerSE, van DijkEJ, et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 2003; 46(12): 1604–10.
DuAT, SchuffN, LaaksoMP, et al. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology 2002; 58(11): 1635–41.
ErkinjunttiT, InzitariD, PantoniL, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 2000; 59: 23–30.
FanYH, ZhangL, LamWW, MokVC, WongKS.Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke 2003; 34(10): 2459–62.
FazekasF, ChawlukJB, AlaviA, HurtigHI, ZimmermanRA.MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Roentgenol 1987; 149(2): 351–6.
FazekasF, KleinertR, RoobG, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. Am J Neuroradiol 1999; 20(4): 637–42.
FazekasF, RopeleS, EnzingerC, et al. MTI of white matter hyperintensities. Brain 2005; 128(Pt 12): 2926–32.
GainottiG, AcciarriA, BizzarroA, et al. The role of brain infarcts and hippocampal atrophy in subcortical ischaemic vascular dementia. Neurol Sci 2004; 25(4): 192–7.
GoscheKM, MortimerJA, SmithCD, MarkesberyWR, SnowdonDA.Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology 2002; 58(10): 1476–82.
GouwAA, van der FlierWM, Van StraatenEC, et al. Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study. J Neurol 2006; 253(9): 1189–96.
GroeschelS, ChongWK, SurteesR, HanefeldF.Virchow–Robin spaces on magnetic resonance images: normative data, their dilatation, and a review of the literature. Neuroradiology 2006; 48(10): 745–54.
GrossmanRI, GomoriJM, RamerKN, LexaFJ, SchnallMD.Magnetization transfer: theory and clinical applications in neuroradiology. Radiographics 1994; 14(2): 279–90.
HachinskiVC, LassenNA, MarshallJ.Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 1974; 2(7874): 207–10.
HoltmannspotterM, PetersN, OpherkC, et al. Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL: a two-year follow-up study. Stroke 2005; 36(12): 2559–65.
KoenneckeHC.Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology 2006; 66(2): 165–71.
KorfES, WhiteLR, ScheltensP, LaunerLJ.Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension 2004; 44(1): 29–34.
KrilJJ, PatelS, HardingAJ, HallidayGM.Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss. J Neurol Neurosurg Psychiatry 2002; 72(6): 747–51.
LesnikOberstein SA, van DenBR, van BuchemMA, et al. Cerebral microbleeds in CADASIL. Neurology 2001; 57(6): 1066–70.
LongstrethWT, Jr., BernickC, ManolioTA, BryanN, JungreisCA, PriceTR.Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol 1998; 55(9): 1217–25.
MaclullichAM, WardlawJM, FergusonKJ, StarrJM, SecklJR, DearyIJ.Enlarged perivascular spaces are associated with cognitive function in healthy elderly men. J Neurol Neurosurg Psychiatry 2004; 75(11): 1519–23.
MungasD, JagustWJ, ReedBR, et al. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease. Neurology 2001; 57(12): 2229–35.
O’BrienJT, PalingS, BarberR, et al. Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology 2001; 56(10): 1386–88.
O’SullivanM, SummersPE, JonesDK, JaroszJM, WilliamsSC, MarkusHS.Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology 2001; 57(12): 2307–10.
O’SullivanM, MorrisRG, HuckstepB, JonesDK, WilliamsSC, MarkusHS.Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry 2004; 75(3): 441–47.
PantelJ, SchroderJ, EssigM, et al. In vivo quantification of brain volumes in subcortical vascular dementia and Alzheimer’s disease. An MRI-based study. Dement Geriatr Cogn Disord 1998; 9(6): 309–16.
RomanGC, TatemichiTK, ErkinjunttiT, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43(2): 250–60.
RomanGC, ErkinjunttiT, WallinA, PantoniL, ChuiHC.Subcortical ischaemic vascular dementia. Lancet Neurol 2002; 1(7): 426–36.
SkehanSJ, HutchinsonM, MacErlaineDP.Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR findings. Am J Neuroradiol 1995; 16(10): 2115–19.
SpiltA, GoekoopR, WestendorpRG, BlauwGJ, de CraenAJ, van BuchemMA.Not all age-related white matter hyperintensities are the same: a magnetization transfer imaging study. Am J Neuroradiol 2006; 27(9): 1964–8.
ScheltensP, ErkinjuntiT, LeysD, et al. White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol 1998; 39(2): 80–9.
van DenBoom, Lesnik ObersteinSA, van DuinenSG, et al. Subcortical lacunar lesions: an MR imaging finding in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Radiology 2002; 224(3): 791–6.
Van der WerfYD, ScheltensP, LindeboomJ, WitterMP, UylingsHB, JollesJ.Deficits of memory, executive functioning and attention following infarction in the thalamus; a study of 22 cases with localised lesions. Neuropsychologia 2003; 41(10): 1330–44.
Van StraatenEC, ScheltensP, KnolDL, et al. Operational definitions for the NINDS-AIREN criteria for vascular dementia. An interobserver study. Stroke 2003; 34(8): 1907–12.
WahlundLO, BarkhofF, FazekasF, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001; 32(6): 1318–22.
WardlawJM, LewisSC, KeirSL, DennisMS, ShenkinS.Cerebral microbleeds are associated with lacunar stroke defined clinically and radiologically, independently of white matter lesions. Stroke 2006; 37(10): 2633–6.
YousryTA, SeelosK, MayerM, et al. Characteristic MR lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Am J Neuroradiol 1999; 20(1): 91–100.

References

De ReuckJ, DecooD, HasenbroekxMC, et al. Acetazolamide vasoreactivity in vascular dementia: a positron emission tomographic study. Eur Neurol 1999; 41(1): 31–6.
DougallNJ, BrugginkS, EbmeierKP. Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia. Am J Geriatr Psychiatry 2004; 12(6): 554–70.
HanyuH, ShimuzuS, TanakaY, TakasakiM, KoizumiK, Abe K. Cerebral blood flow patterns in Binswanger’s disease: a SPECT study using three-dimensional stereotactic surface projections. J Neurol Sci 2004; 220(1–2): 79–84.
JagustWJ, JohnsonKA, HolmanBL. SPECT perfusion imaging in the diagnosis of dementia. J Neuroimaging 1995; 5 Suppl 1: S45–52.
KomataniA, YamaguchiK, SugaiY, et al. Assessment of demented patients by dynamic SPECT of inhaled xenon-133. J Nucl Med 1988; 29(10): 1621–6.
LojkowskaW, RyglewiczD, JedrzejczakT, et al. The effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer’s disease and vascular dementia. J Neurol Sci 2003; 216(1): 119–26.
MielkeR, PietrzykU, JacobsA, et al. HMPAO SPECT and FDG PET in Alzheimer’s disease and vascular dementia: comparison of perfusion and metabolic pattern. Eur J Nucl Med 1994; 21(10): 1052–60.
PavicsL, GrunwaldF, ReichmannK, et al. rCBF SPECT and the acetazolamide test in the evaluation of dementia. Nucl Med Rev Cent East Eur 1998; 1(1): 13–19.
ScheidR, PreulC, LinckeT, et al. Correlation of cognitive status, MRI- and SPECT-imaging in CADASIL patients. Eur J Neurol 2006; 13(4): 363–70.
ShimYS, YangDW, KimBS, ShonYM, ChungYA. Comparison of regional cerebral blood flow in two subsets of subcortical ischemic vascular dementia: statistical parametric mapping analysis of SPECT. J Neurol Sci 2006; 250 (1–2): 85–91.
TalbotPR, LloydJJ, SnowdenJS, NearyD, TestaHJ. A clinical role for 99m Tc-HMPAO SPECT in the investigation of dementia?J Neurol Neurosurg Psychiatry 1998; 64(3): 306–13.
YangDW, KimBS, ParkJK, KimSY, KimEN, SohnHS. Analysis of cerebral blood flow of subcortical vascular dementia with single photon emission computed tomography: adaptation of statistical parametric mapping. J Neurol Sci 2002; 203–204: 199–205.
YoshikawaT, MuraseK, OkuN, et al. Quantification of the heterogeneity of cerebral blood flow in vascular dementia. J Neurol 2003a; 250(2): 194–200.
YoshikawaT, MuraseK, OkuN, et al. Statistical image analysis of cerebral blood flow in vascular dementia with small-vessel disease. J Nucl Med 2003b; 44(4): 505–11.
YoshikawaT, MuraseK, OkuN, et al. Heterogeneity of cerebral blood flow in Alzheimer disease and vascular dementia. AJNR 2003c; 24(7): 1341–7.

References

AdairJC, CharlieJ, DencoffJE,et al. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke 2004; 35: e159–62.
AnandN, SteadLG.Neuron-specific enolase as a marker for acute ischemic stroke: a systematic review. Cerebrovasc Dis 2005; 20: 213–19.
BarbaR, Martinez-EspinosaS, Rodriguez-GarciaE, PondalM, VivancosJ, Del SerT.Poststroke dementia: clinical features and risk factors. Stroke 2000; 31: 1494–501.
BarberM, TaitRC, ScottJ, et al. Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation. J Thromb Haemost 2004; 2: 1873–8.
BatemanEJ, MunsellLY, MorrisJC,et al. Human amyloid- β synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nature Med 2006; 12: 856–61.
BlaskoI, JellingerK, KemmlerG, et al. Conversion from cognitive health to mild cognitive impairment and Alzheimer’s disease: Prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine. DOI:10.1016/j.neurobiolaging/2006.09.002
BlennowK, WallinA, EkmanR.Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders?J Neural Transm Park Dis Dement Sect 1994; 8: 183–91.
BlennowK, WallinA, ÅgrenH, et al. Tau protein in cerebrospinal fluid. A biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 1995; 26: 231–44.
BlennowK, HampelH.CSF markers for incipient Alzheimer’s disease. Lancet Neurol 2003; 2: 605–13.
BonelliRM, AschoffA, NiederwieserG, HeubergerC, JirikowskiG.Cerebrospinal fluid tissue transglutaminase as a biochemical marker for Alzheimer’s disease. Neurobiol Dis 2002; 11: 106–10.
BotsML, BretelerMM, van KootenFR,et al. Coagulation and fibrinolysis markers and risk of dementia. Haemostasis 1998; 28: 216–22.
BoysenG, BranderT, ChristensenH, GideonR, TruelsenT.Homocysteine and risk of recurrent stroke. Stroke 2003; 34: 1258–61.
ClarkCM, XieS, ChittamsJ, et al. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol 2003 Dec; 60(12): 1696–702.
DaneshJ, CollinsR, PetoR.Lipoprotein(a) and coronary heart disease: meta-analysis of prospective studies. Circulation 2000; 102: 1082–5.
De LuigiA, PizzimentiS, QuadriP, et al. Peripheral inflammatory response in Alzheimer’s disease and multiinfarct dementia. Neurobiol Dis 2002; 11: 308–14.
EngelhartMJ, GeerlingsMI, MeijerJ, et al. Inflammatory proteins in plasma and the risk of dementia. The Rotterdam Study. Arch Neurol 2004; 61: 668–72.
EsiriMM, NagyZ, SmithMZ, BarnetsonL, SmithAD.Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer’s disease. Lancet 1999; 354: 919–20.
FaganAM, MintunMA, MachRH, et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans. Ann Neurol 2006; 59: 512–9.
FredmanP, WallinA, BlennowK, et al. Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia. Acta Neurol Scand 1992; 85: 103–6.
GranthamC, GeertsH.The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease. Neurol Sci 2002; 202–204(C): 131–6.
GuptaA, WatkinsA, ThomasP, et al. Coagulation and inflammation in Alzheimer’s and vascular dementia. Int J Clin Pract 2005; 59: 52–7.
HansraniM, StansbyG.Homocysteine lowering interventions for peripheral arterial disease and bypass grafts. Cochrane Database of Systematic Reviews 2002; Issue 3: CD003285.
HanssonO, ZetterbergH, BuchhaveP,et al. Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006; 5: 228–34.
HassanA, HuntBJ, O’SullivanM, et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004; 127: 212–9.
HenonH, PasquierF, DurieuI, et al. Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. Stroke 1997; 28: 2429–36.
HerukkaSK, HallikainenM, SoininenH, PirttiläT.The combination of CSF Ab42 and tau or phosphorylated tau helps to predict progressive mild cognitive impairment. Neurology 2005; 65: 1294–7.
HesseC, RosengrenL, VanmechelenE, et al. Cerebrospinal fluid markers for Alzheimer’s disease evaluated after acute ischemic stroke. J Alzheimer Dis 2000; 2: 199–206.
HogervorstE, Mendes RibeiroH, MolyneuxA, BudgeM, SmithD.Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer’s disease. Arch Neurol 2002; 59: 787–93.
HuYY, HeSS, WangX, et al. Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer’s disease patients: an ultrasensitive bienzyme–substrate–recycle enzyme-linked immunosorbent assay. Am J Pathol 2002; 160: 1269–78.
HulstaertF, BlennowK, IvanoiuA, et al. Improved discrimination of AD patients using β-amyloid1-42 and tau levels in CSF. Neurology 1999; 52: 1555–62.
LipGYH, BlannAD, FarooqiIS,et al. Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute stroke patients: the West Birmingham Stroke Project. Blood Coagul Fibrinol 2001; 12: 307–15.
Longstreth WTJr., KatzR, OlsonJ, et al. Plasma total homocysteine levels and cranial magnetic resonance imaging findings in elderly persons: the Cardiovascular Health Study. Arch Neurol 2004; 61: 67–72.
MariP, ParnettiL, CoppolaR, et al. Haemostatic abnormalities in patients with vascular dementia and Alzheimer’s disease. Thromb Haemost 1996; 75: 216–8.
MayeuxR, TangMX, JacobsDM,et al. Plasma amyloid beta-peptide 1–42 and incipient Alzheimer’s disease. Ann Neurol 1999; 46(3): 412–16.
McllroySP, DynanKB, LawsonJT, et al. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk of stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002; 33: 2351–6.
MeiklejohnDJ, VickersMA, DijkhuisenR, GreavesM.Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke. Stroke 2001; 32: 57–62.
MollerJ, NielsenGM, TvedegaardKC, AndersenNT, JorgensenPE.A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia. Scand J Clin Lab Invest 2000; 60: 491–500.
MorrisMS. Homocysteine and Alzheimer’s disease. Lancet Neurol 2003; 2: 425–8.
NemesZ, FesusL, EgerhaziA, KeszthelyiA, DegrellIM.N(epsilon)(gamma-glutamyl)lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia. Neurobiol Aging 2001 May–Jun; 22(3): 403–06.
Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001; 357: 169–75.
NurkE, RefsumH, TellGS, et al. Plasma homocysteine and memory in the elderly: the Horhaland homocysteine study. Ann Neurol 2005; 58: 847–57.
NäggaK, GottfriesJ, BlennowK, MarcussonJ.Cerebrospinal fluid phospho-tau, total tau and β-amyloid1–42 in the differentiation between Alzheimer’s disease and vascular dementia. Dementia Geriatr Cogn Disord 2002; 14: 183–90.
OlssonY, BrunA, EnglundE.Fundamental pathological lesions in vascular dementia. Acta Neurol Scand Suppl 1996; 168: 31–8.
OttoM, WiltfangJ, TumaniH, et al. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease. Neurosci Lett 1997; 225: 210–12.
PantoniL, BasileAM, RomanelliM, et al. Abulia and cognitive impairment in two patients with capsular genu infarct. Acta Neurol Scand 2001; 104: 185–90.
ParnettiL, PalumboB, CardinaliL, et al. Cerebrospinal fluid neuron-specific enolase in Alzheimer’s disease and vascular dementia. Neurosci Lett 1995; 183: 43–5.
RomanGC, ErkinjunttiT, WallinA, PantoniL, ChuiHC.Subcortical ischemic vascular dementia. Lancet Neurol 2002; 1: 426–36.
SachdevPS, BrodatyH, ValenzuelaMJ, et al. Clinical determinants of dementia and mild cognitive impairment following ischemic stroke: the Sydney Stroke Study. Dement Geriatr Cogn Disord 2006; 21(5–6): 275–83.
SachdevPS, ValenzuelaMJ, BrodatyH, et al. Homocysteine as a risk factor for cognitive impairment in stroke patients. Dement Geriatr Cogn Disord 2003; 15: 155–62.
ScheunerD, EckmanC, JensenM, et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nat Med 1996; 2(8): 864–70.
SchmidtR, SchmidtH, CurbJD, et al. Early inflammation and dementia: a 25-year follow-up of the Honolulu–Asia Aging Study. Ann Neurol 2002; 52: 168–74.
SjögrenM, MinthonL, DavidssonP,et al. CSF levels of tau, β-amyloid 1–42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging. J Neural Transm 2000; 107: 563–79.
SjögrenM, BlombergM, JonssonM, et al. Neurofilament protein in cerebrospinal fluid: a marker of white matter changes. J Neurosci Res 2001; 66: 510–16.
SmithFB, LeeAJ, FowkesFG, et al. Haemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1997; 17: 3321–5.
SnowdonDA, GreinerLH, MortimerJA, RileyKP, GreinerPA, MarkesberyWR.Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997; 277: 813–17.
SobowT, FlirskiM, KloszewskaI, LiberskiPP.Plasma levels of alpha beta peptides are altered in amnestic mild cognitive impairment but not in sporadic Alzheimer’s disease. Acta Neurobiol Exp (Wars) 2005; 65: 117–24.
StottDJ, SpilgE, CampbellAM, et al. Haemostasis in ischemic stroke and vascular disease. Blood Coagul Fibrinol 2001; 12: 651–7.
StrozykD, BlennowK, WhiteLR, LaunerLJ.CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 2003; 60: 652–6.
TapiolaT, LehtovirtaM, RambergJ, et al. CSF tau is related to apolipoprotein E genotype in early Alzheimer’s disease. Neurology 1998; 50: 169–74.
TarkowskiE, BlennowK, WallinA, TarkowskiA.Intrathecal production of tumor necrosis factor-α, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol 1999; 19: 223–30.
TarkowskiE, WallinA, ReglandB, BlennowK, TarkowskiA.Local and systemic GM-CSF increase in Alzheimer’s disease and vascular dementia. Acta Neurol Scand 2001; 103: 166–74.
TarkowskiE, IssaR, SjogrenM, et al. Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer’s disease and vascular dementia. Neurobiol Aging 2002; 23: 237–43.
TarkowskiE, TullbergM, FredmanP, WikkelsoC.Correlation between intrathecal sulfatide and TNF-alpha levels in patients with vascular dementia. Dement Geriatr Cogn Disord 2003; 15: 207–11.
The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. JAMA 2002; 288: 2015–22.
TohgiH, AbeT, KimuraM, SahekiM, TakahashiS.Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J Neural Transm 1996; 103: 1211–20.
TomimotoH, AkiguchiI, OhtaniR, et al. Coagulation activation in patients with Binswanger disease. Arch Neurol 1999; 56: 1104–08.
TooleJF, MalinowMR, ChamblessLE,et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004; 291: 565–75.
de la TorreJC.Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002; 33: 1152–62.
TullbergM, ManssonJE, FredmanP, et al. CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy. J Neurol Neurosurg Psychiatry 2000; 69: 74–81.
UrakamiK, Wada IsoeK, WakutaniY, et al. Lipoprotein (a) phenotype in patients with vascular dementia. Dement Geriatr Cogn Disord 2000; 11: 135–8.
van OijenM, HofmanA, SoaresHD, KoudstaalPJ, BretelerMM.Plasma Abeta(1–40) and Abeta(1–42) and the risk of dementia: a prospective case-cohort study. Lancet Neurol 2006; 5: 655–60.
VermeerSE, Den HeijerT, KoudstaalPJ, et al. Incidence and risk factors of silent brain infarcts in the population based Rotterdam Scan Study. Stroke 2003; 34: 392–6.
Wada-IsoeK, WakutaniY, UrakamiK, NakashimaK.Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients. Acta Neurol Scand 2004 Aug; 110(2): 124–7.
WallinA, BlennowK.Heterogeneity of vascular dementia – mechanisms and subgroups. Int J Geriatr Psychiatry Neurol 1993; 6: 177–88.
WallinA, SjögrenM.Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia. Mech Ageing Develop 2001; 122: 1937–49.
WallinA, SjögrenM, BlennowK, DavidssonP.Decreased cerebrospinal fluid acetylcholinesterase in patients with subcortical ischemic vascular dementia. Dement Geriatr Cogn Disord 2003; 16: 200–07.
WrightCB, PaikMC, BrownTR, et al. Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke 2005; 36: 1207–11.
YaffeK, KanayaA, LindquistK, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292: 2237–42.
ZekryD, HauwJJ, GoldG.Mixed dementia: epidemiology, diagnosis, and treatment. J Am Geriatr Soc 2002; 50: 1431–8.
ZemlanFP, RosenbergWS, LuebbePA, et al. Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins. J Neurochem 1999; 72: 741–50.
ZulianiG, RanziniM, GuerraG, et al. Plasma cytokines profile in older subjects with late onset Alzheimer’s disease or vascular dementia. J Psychiatr Res 2007; 41: 686–93.